Emerging Implant Technologies (EIT) received FDA 510(k) clearance for 3D-printed spinal interbody devices to address anterior, transforaminal and posterior lumbar interbody fusion and cervical procedures.
The implants are manufactured from EIT Cellular Titanium® that yields a porosity of 80% and is designed to address clinical shortcomings such as non-fusion, biocompatibility, subsidence, migration and imaging distortion.
EIT is based in Germany. Since 2014, >10,000 cases have been performed with its products around the world.
Emerging Implant Technologies (EIT) received FDA 510(k) clearance for 3D-printed spinal interbody devices to address anterior, transforaminal and posterior lumbar interbody fusion and cervical procedures.
The implants are manufactured from EIT Cellular Titanium® that yields a porosity of 80% and is designed to address clinical shortcomings...
Emerging Implant Technologies (EIT) received FDA 510(k) clearance for 3D-printed spinal interbody devices to address anterior, transforaminal and posterior lumbar interbody fusion and cervical procedures.
The implants are manufactured from EIT Cellular Titanium® that yields a porosity of 80% and is designed to address clinical shortcomings such as non-fusion, biocompatibility, subsidence, migration and imaging distortion.
EIT is based in Germany. Since 2014, >10,000 cases have been performed with its products around the world.
Our site uses cookies to allow easier access for Members and subscribers and to improve our site. You agree to our use of cookies by closing this message box or continuing to use our site.OkRead more
Copy to clipboard 
